rapid
spread
human
main
group
evolv
ten
distinct
subtyp
undergon
countless
recombin
event
diversifi
extens
impact
extrem
genet
divers
phenotyp
recent
becom
research
focu
earli
find
indic
domin
subtyp
c
current
epidem
might
relat
lower
virul
subtyp
compar
subtyp
explor
whether
reach
peak
virul
alreadi
start
slow
path
attenu
four
classifi
retrovirus
infect
human
caus
symptomat
diseas
human
tcell
lymphotrop
viru
htlv
type
member
deltaretroviru
genu
subfamili
orthoretrovirina
show
low
rate
evolut
human
popul
probabl
origin
nonhuman
primat
million
year
ago
high
frequenc
infect
local
specif
endem
area
exampl
southern
japan
recent
time
indic
rel
slow
spread
human
popul
compar
anoth
human
retroviru
introduc
human
popul
year
ago
estim
million
individu
current
infect
viru
spread
expans
across
africa
throughout
world
accompani
one
rapid
evolutionari
rate
describ
human
pathogen
asid
hepat
c
viru
remain
one
lethal
pathogen
mortal
current
infect
human
wherea
infect
human
virus
often
fear
ebola
sever
acut
respiratori
syndrom
sar
influenza
lassa
fever
mortal
rate
whether
lethal
pathogen
evolv
becom
rel
benign
parasit
even
commens
organ
subject
great
debat
surviv
euroasian
popul
european
bubon
plagu
influenza
epidem
often
perceiv
evid
pathogen
attenu
howev
neither
yersinia
pesti
influenza
viru
seem
attenu
rel
short
human
epidem
surviv
pesti
epidem
thought
relat
fraction
human
popul
resist
rodent
ectoparasit
possibl
select
resist
human
host
nonetheless
mani
exampl
microparasit
evolut
host
select
lead
attenu
resist
diseas
best
document
control
exampl
rapid
outgrowth
attenu
myxoma
viru
follow
introduct
australia
control
expand
rabbit
popul
viru
might
attenu
result
alter
immunomodulatori
properti
addit
reduct
replic
rate
recent
analys
archiv
report
fifteenth
centuri
suggest
dramat
decreas
sever
syphili
symptom
took
place
period
less
year
relat
reduct
virul
rather
select
resist
host
rapid
decad
centuri
versu
slow
thousand
million
year
attenu
might
relat
sever
diseas
rate
lethal
transmiss
effici
transmiss
rout
suggest
simian
lentivirus
attenu
nonhuman
primat
host
million
year
coevolut
challeng
recent
phylogenet
analys
indic
introduct
simian
immunodefici
viru
siv
african
primat
might
rel
recent
event
unfold
past
hundr
thousand
year
therefor
indic
primat
lentivirus
might
frequent
jump
primat
speci
rapidli
adapt
new
host
studi
model
expans
contract
variou
epidem
indic
interrelationship
lethal
pathogen
host
complex
frequent
compar
question
answer
understand
pathogen
evolut
dynam
spread
within
popul
larg
within
infect
host
propens
evolv
rapidli
respons
variou
immun
host
pressur
indic
viru
like
becom
attenu
reduct
virul
rather
select
resist
host
phylogenet
approach
commonli
use
describ
evolut
pathogen
examin
genet
differ
actual
impact
physic
attribut
often
term
fit
pathogen
understand
given
complex
measur
fit
defin
adapt
reproduct
success
organ
specif
environ
case
research
fit
frequent
misrepres
overinterpret
exampl
virion
revers
transcriptas
rt
harbour
mutat
confer
resist
antiretrovir
drug
arv
lamivudin
epivir
seem
less
fit
virion
carri
wildtyp
rt
howev
reduc
fit
reconstitut
vitro
assay
necessarili
impli
drugresist
viru
less
fit
human
host
receiv
arv
fit
evolv
less
virul
form
human
environ
interrel
necessarili
consequenti
purpos
opinion
articl
fit
defin
specif
environ
signific
correl
environ
highlight
potenti
consequenti
fit
alway
synonym
virul
typic
defin
rate
host
mortal
consequ
infect
refin
includ
reproduct
rate
pathogen
potenti
pathogen
paramet
also
defin
fit
pathogen
within
host
typic
virul
difficult
measur
virus
given
long
asymptomat
period
infect
therefor
intermitt
measur
replic
fit
diseas
often
provid
insight
rate
diseas
progress
confus
principl
virul
fit
introduc
examin
fit
within
host
compar
examin
fit
within
popul
maynard
ewald
anderson
may
novak
other
suggest
pathogen
strain
slow
replic
fit
high
transmiss
effici
favour
host
popul
strain
b
increas
replic
fit
howev
strain
compet
togeth
singl
host
clear
strain
b
virul
would
outcompet
consequ
fitter
strain
term
pathogen
spread
host
popul
high
pathogen
fit
defin
reduct
reproduct
rate
virul
without
loss
transmiss
articl
address
possibl
direct
relationship
virul
replic
fit
import
note
attenu
virul
alway
synonym
lower
replic
capac
exampl
attenu
myxoma
virul
australian
rabbit
popul
might
relat
chang
virusmedi
immunomodul
lower
replic
fit
rabbit
expans
human
first
introduc
human
popul
chimpanze
subspeci
pan
troglodyt
troglodyt
recent
keel
et
al
discov
region
southern
cameroon
chimpanze
carri
siv
strain
siv
cpzptt
close
relat
two
distinct
lineag
main
new
n
group
fig
origin
outlier
group
might
relat
jump
gorilla
gorilla
siv
cpzptt
introduc
human
popul
multipl
time
decad
possibl
centuri
transfer
event
probabl
start
increas
result
human
migrat
dens
tropic
region
similar
pend
introduct
influenza
avian
human
host
distinct
possibl
rare
siv
cpzptt
strain
might
capac
effici
replic
sexual
transmiss
human
follow
founder
event
human
popul
densiti
contact
suffici
high
subsequ
transmiss
spread
possibl
singl
transmiss
group
spawn
million
infect
taken
place
sinc
begin
epidem
contrast
origin
human
crossspeci
transmiss
sooti
mangabey
west
africa
near
guineabissau
around
incid
group
central
africa
west
africa
expand
exponenti
clearli
differ
rate
preval
infect
million
far
exce
infect
million
stark
contrast
group
n
respons
infect
cameroon
gabon
expans
diverg
evolut
group
divers
subtyp
fig
date
might
coincid
human
emigr
seed
new
region
epidem
central
africa
subtyp
share
sequenc
ident
group
share
differ
much
nucleotid
level
fig
given
extrem
genet
divers
reason
assum
hiv
type
group
subtyp
even
isol
evolv
maintain
similar
virul
although
mani
research
articl
describ
genotyp
differ
subtyp
hand
studi
examin
potenti
phenotyp
differ
among
human
lenti
virus
studi
model
phenotyp
fit
differ
among
virus
might
affect
diseas
progress
infect
individu
gener
spread
viru
human
popul
articl
provid
predict
tempor
attenu
base
publish
studi
signific
trend
human
epidem
understand
attenu
virul
occur
import
understand
popul
dynam
fit
infect
host
hosttohost
transmiss
infect
evolv
host
relat
sexual
transmit
pathogen
transmit
moder
effici
sexual
contact
appar
greater
effici
direct
bloodtoblood
contact
exampl
needl
share
intraven
drug
user
vertic
mothertochild
perinat
transmiss
mani
case
discord
coupl
hivposit
individu
fail
transmit
viru
uninfect
partner
despit
frequent
opportun
schemat
transmiss
event
diseas
progress
provid
fig
increas
viral
load
donor
consequ
inocul
dose
increas
transmiss
effici
increas
viral
load
donor
also
correspond
greater
genet
divers
inocul
popul
term
viru
isol
fig
yet
clone
establish
infect
recipi
dramat
bottleneck
might
relat
access
initi
target
cell
cell
dendrit
lineag
establish
product
system
infect
base
extens
studi
rna
virus
clear
restrict
genet
bottleneck
invok
variou
select
pressur
reduc
replic
fit
unfortun
nearli
viral
fit
studi
done
tissuecultur
infect
anim
model
defin
donorrecipi
transmiss
pair
greater
genet
divers
acut
earli
infect
associ
rapid
diseas
progress
addit
genet
divers
seem
correl
directli
replic
fit
hiv
obviou
aetiolog
agent
aid
yet
commonli
assum
phenotyp
characterist
replic
effici
ex
vivo
fit
infect
wildtyp
hiv
isol
littl
impact
rate
diseas
progress
much
attent
focus
host
correl
diseas
progress
strength
hivspecif
immun
respons
host
genet
polymorph
might
affect
replic
rna
load
remain
best
predictor
hiv
diseas
progress
dramat
reduct
load
achiev
arv
treatment
delay
diseas
progress
import
note
high
viral
load
absolut
relat
sever
diseas
nonhuman
host
sooti
mangabey
high
siv
load
associ
clinic
symptom
recent
studi
indic
declin
tcell
count
increas
viral
load
better
predictor
diseas
progress
phylogenet
tree
base
nucleotid
distanc
construct
neighbourjoin
method
implement
clustalx
bootstrap
resampl
present
schemat
repres
treeview
program
share
sequenc
ident
cluster
distinct
locat
phylogenet
tree
wherea
siv
cpz
branch
root
group
origin
group
southern
cameroon
recent
describ
indic
two
probabl
jump
chimpanze
group
n
gorilla
group
speci
subtyp
probabl
evolv
discret
introduct
human
popul
diverg
differ
subtyp
subtyp
defin
alik
describ
isol
sequenc
map
phylogenet
subtyp
subtyp
exampl
recombin
form
agngibng
group
alik
cluster
longer
genom
segment
relat
subtyp
subtyp
g
main
n
new
first
evid
specif
viral
genet
trait
might
affect
virul
identif
longterm
nonprogress
individu
harbour
defect
isol
lack
nef
open
read
frame
mutat
delet
accessoryproteincod
gene
significantli
impair
fit
tissuecultur
infect
even
discoveri
year
ago
effect
rel
replic
fit
diseas
progress
subject
intens
studi
owe
difficulti
accur
measur
fit
limit
studi
examin
viru
fit
chang
natur
infect
replic
capac
differ
isol
commonli
compar
measur
ex
vivo
growth
kinet
singl
viru
infect
virus
use
mani
studi
isol
infect
patient
rather
chimer
recombin
virus
contain
gene
patient
viru
within
genom
laboratori
strain
small
environment
differ
separ
singl
viru
infect
inher
variabl
detect
assay
prevent
accur
estim
viral
fit
method
contrast
dual
viru
infect
competit
assay
involv
multipl
round
viru
replic
less
affect
environment
chang
result
quantifi
small
signific
differ
fit
hiv
research
multipl
singlecycl
singl
viru
infect
competit
experi
use
studi
describ
impair
replic
fit
confer
drugresist
mutat
nevertheless
impact
drug
resist
mutat
primari
isol
oppos
chimer
virus
fulli
assess
initi
report
use
competit
assay
peripher
blood
mononuclear
cell
pbmc
cultur
measur
fit
indic
mani
longterm
survivor
harbour
impair
replic
capac
wherea
rapid
progressor
infect
aggress
isol
subsequ
studi
indic
genet
divers
fit
intrapati
popul
continu
increas
diseas
diverg
founder
clone
fig
divers
reach
inflect
point
incept
aid
symptom
asymptomat
period
steadi
increas
divers
occur
concomitantli
increas
viral
load
significantli
increas
ex
vivo
replic
fit
infect
isol
fig
red
queen
dynam
interact
parasit
host
lead
constant
evolutionari
process
adapt
counteradapt
predict
increas
replic
fit
must
associ
continu
expans
genet
breadth
size
popul
strong
select
pressur
result
contract
popul
size
appear
deleteri
mutat
decreas
fit
interestingli
introduct
arv
strong
select
pressur
asymptomat
diseas
result
dramat
decreas
load
genet
divers
replic
fit
even
absenc
drug
resist
mutat
follow
transmiss
possibl
replic
fit
genet
divers
newli
infect
isol
lower
inocul
viru
donor
continu
increas
divers
fit
direct
conflict
idea
hivspecif
acquir
immun
respons
counter
viral
expans
discrep
data
might
simpli
due
time
period
sampl
analys
genet
divers
fit
increas
first
one
two
year
infect
fig
immedi
follow
acut
infect
host
genet
hivspecif
immun
respons
might
crucial
role
establish
genet
divers
fit
set
point
might
also
correspond
welldocu
viralload
set
point
fig
cellmedi
immun
could
domin
factor
specif
reduc
viral
load
consequ
fit
divers
gene
human
leukocyt
antigen
hla
loci
extrem
variabl
human
geograph
region
typic
rare
find
perfect
match
hla
ag
allel
encod
major
histocompat
complex
mhc
class
six
hla
gene
encod
mhc
class
ii
even
region
specif
ethnic
consider
popul
divers
hla
allel
encompass
least
major
b
c
allel
see
dbmhc
web
site
compar
eurasian
popul
hla
divers
much
greater
main
ethnic
group
subsaharan
africa
studi
individu
character
b
c
loci
found
prefer
singl
allel
least
hla
divers
often
observ
homogen
caucasian
popul
notabl
caucasian
australian
popul
see
dbmhc
web
site
might
human
popul
divers
term
hla
type
host
polymorph
influenc
evolut
figur
hypothet
exampl
chang
replic
fit
viral
load
diseas
progress
individu
typic
infect
clone
depict
small
green
circl
dramat
increas
copi
number
genet
divers
first
month
infect
follow
acut
infect
period
viral
load
reduc
partli
result
strong
hivspecif
cellmedi
immun
viru
popul
thought
oscil
expans
popul
owe
immun
escap
exist
hivspecif
cytotox
tlymphocyt
ctl
clone
contract
caus
new
genet
bottleneck
induc
newli
emerg
ctl
clone
replic
fit
genet
divers
popul
seem
track
close
togeth
follow
earli
diseas
purpl
box
increas
rel
linear
rate
length
infect
increas
replic
fit
correl
increas
viral
load
right
axi
decreas
tcell
count
shown
scale
replic
fit
arbitrari
deriv
rel
fit
valu
abil
one
isol
outcompet
anoth
ex
vivo
dualviru
competit
experi
quantit
aspect
hivspecif
immun
respons
exampl
high
level
hivspecif
cytotox
lymphocyt
ctl
versu
low
level
selflimit
immun
transfer
individu
howev
qualit
differ
term
immun
system
see
infect
strain
could
signific
impact
virul
mismatch
hla
gene
donor
recipi
transmiss
pair
would
result
present
differ
set
peptid
epitop
cell
recipi
recogn
donor
new
transmiss
infect
viru
must
evolv
escap
pressur
turn
seem
reduc
replic
fit
human
popul
low
hla
divers
exampl
australia
ctl
escap
mutat
might
becom
fix
along
compensatori
mutat
restor
maintain
virul
contrast
constant
passag
human
differ
hla
type
exampl
africa
might
prevent
accumul
compensatori
mutat
could
stabil
ctl
escap
mutat
howev
model
involv
hla
type
obvious
simplist
consid
effect
host
factor
exampl
polymorph
host
restrict
factor
could
also
alter
diseas
progress
furthermor
host
polymorph
coreceptor
ligand
exampl
alter
coreceptor
ligand
express
level
affect
abil
use
coreceptor
polymorph
exist
high
frequenc
human
popul
could
result
oscil
sequenc
exampl
reduc
increas
coreceptor
avid
correl
replic
fit
gener
virul
might
attenu
averag
loss
fit
occur
follow
transmiss
greater
gain
replic
fit
occur
asymptomat
diseas
progress
loss
fit
probabl
due
genet
bottleneck
transmiss
andor
escap
host
restrict
host
immun
respons
earli
diseas
continu
introduct
new
select
pressur
genet
bottleneck
would
lead
accumul
deleteri
mutat
turn
would
reduc
replic
fit
virul
howev
hypothes
empir
test
use
transmiss
pair
figur
show
model
attenu
human
popul
divers
limit
genet
polymorph
associ
diseas
progress
illustr
patient
founder
infect
patient
b
approxim
year
infect
transmiss
patient
patient
b
replic
pathogen
fit
viru
increas
arbitrari
unit
see
fig
legend
although
replic
fit
increas
patient
transmiss
patient
patient
b
result
genet
bottleneck
reset
fit
lower
baselin
set
level
dot
line
patient
b
hla
match
cellmedi
immun
respons
ctl
respons
patient
b
recogn
differ
set
epitop
patient
patient
b
mutat
new
set
epitop
necessari
ctl
escap
viru
expand
face
antivir
respons
howev
escap
ctl
respons
come
fit
cost
reduc
replic
fit
first
year
infect
follow
escap
infect
isol
seem
continu
increas
number
viral
load
increas
gain
replic
fit
fig
process
repeat
transmiss
event
patient
divers
hla
allel
patient
b
transmit
patient
c
patient
c
transmit
patient
acut
infect
increas
transmiss
effici
associ
higher
viral
load
highest
acut
infect
howev
short
time
interv
acut
infect
provid
limit
opportun
transmiss
diseas
progress
viral
load
increas
effici
transmiss
increas
even
though
opportun
transmiss
remain
constant
consequ
transmiss
event
might
result
prolong
compar
rapid
diseas
progress
exampl
transmiss
patient
e
even
account
high
transmiss
effici
acut
infect
model
owe
fit
bottleneck
transmiss
subsequ
loss
fit
caus
ctl
escap
circul
isol
start
lose
virul
loss
virul
would
decreas
pathogenesi
prolong
time
aid
even
result
nonsymptomat
infect
complet
clearanc
unlik
stabl
integr
proviru
memori
cell
long
half
live
possibl
reactiv
viru
replic
cell
patient
limit
genet
divers
possibl
hla
match
loss
fit
might
associ
genet
bottleneck
follow
transmiss
infect
isol
could
resist
breadth
possibl
ctl
respons
exampl
patient
transmit
patient
x
year
infect
year
isol
patient
mutat
domin
epitop
escap
ctl
activ
patient
infect
patient
x
match
hla
allel
viru
patient
effici
recogn
ctl
respons
patient
x
could
result
rapid
diseas
progress
isol
pass
patient
limit
hla
divers
might
actual
increas
virul
ctl
cytotox
lymphocyt
hla
human
leukocyt
antigen
evid
attenu
except
anecdot
case
report
one
publish
studi
larg
cohort
evid
virul
either
increas
decreas
past
year
pandem
one
main
obstacl
compar
diseas
progress
current
day
epidem
develop
world
signific
medic
advanc
made
develop
world
recent
cohort
analys
diseas
progress
final
owe
increas
awar
educ
aid
patient
diagnos
earlier
sometim
acut
infect
wherea
mani
patient
present
clinic
onset
aid
result
often
impress
infect
less
aggress
begin
pandem
studi
publish
last
year
primari
isol
obtain
patient
sampl
antwerp
belgium
twelv
could
match
period
virus
time
period
compet
pbmc
hivneg
donor
base
headtohead
viru
competit
experi
recent
isol
significantli
less
fit
histor
isol
find
indic
might
attenu
replic
fit
past
year
fit
infect
strain
predictor
diseas
progress
reduc
ex
vivo
fit
pbmc
might
strong
correl
decreas
virul
howev
result
interpret
caution
owe
limit
sampl
size
involv
furthermor
crosssect
design
studi
result
sampl
isol
singl
time
point
diseas
progress
control
diseas
stage
base
tcell
count
viral
load
nonetheless
increas
fit
virus
versu
virus
signific
greater
increas
fit
observ
diseas
progress
futur
studi
larg
cohort
span
epidem
tempor
variou
geograph
region
warrant
describ
studi
limit
analys
virul
replic
fit
rate
diseas
progress
avail
see
rate
diseas
progress
examin
european
hivinfect
cohort
span
year
ref
slope
tcell
declin
calcul
antiretroviraltreatmentna
patient
confirm
date
infect
fewer
nine
time
point
period
year
follow
earli
period
aid
epidem
seem
evid
slow
rate
diseas
progress
interestingli
period
follow
also
correspond
increas
use
combin
arv
treatment
could
indirectli
relat
attenu
none
patient
receiv
arv
studi
period
possibl
drug
resist
mutat
might
appear
higher
frequenc
suboptim
treatment
widespread
use
highli
activ
antiretrovir
therapi
haart
mutat
associ
reduc
fit
presenc
follow
new
transmiss
absenc
arv
treatment
low
would
fulli
explain
rate
diseas
progress
might
decreas
detect
fluctuat
rate
tcell
declin
start
epidem
europ
surpris
given
preliminari
data
suggest
replic
fit
might
higher
compar
ref
slope
tcell
declin
heavili
influenc
length
longitudin
followup
followup
period
postinfect
number
data
point
exampl
patient
present
clinic
advanc
diseas
slope
tcell
declin
commonli
lower
earli
diseas
especi
level
fall
cell
per
therefor
slow
diseas
progress
might
associ
accrual
patient
advanc
diseas
gener
natur
histori
cohort
start
earli
acut
infect
end
aidsdefin
ill
morbid
typic
year
without
arv
treatment
provid
best
estim
tcell
declin
diseas
progress
rate
develop
world
cohort
readili
avail
owe
late
diagnosi
wherea
current
cohort
difficult
assess
natur
histori
diseas
due
arv
intervent
final
given
reduc
hla
divers
greater
ethnic
homogen
caucasian
popul
attenu
rate
subtyp
b
virul
might
less
dramat
attenu
possibl
nonb
subtyp
subsaharan
africa
vivo
ex
vivo
fit
differ
earli
observ
rate
diseas
progress
west
africa
show
infect
less
aggress
infect
also
transmit
less
frequent
human
popul
similar
demograph
similar
opportun
sexual
contact
wherea
spread
across
globe
founder
event
area
west
africa
result
region
epidem
fig
even
infect
evenli
distribut
among
differ
group
subtyp
group
n
infect
character
five
cameroonian
wherea
group
infect
estim
cameroon
gabon
group
subtyp
c
spread
rapidli
subtyp
partli
result
recent
subtyp
c
pandem
southern
africa
south
america
asia
fig
supplementari
inform
tabl
pure
subtyp
c
recombin
form
contain
least
envelop
gene
subtyp
c
respons
infect
worldwid
founder
event
subtyp
c
ccontain
recombin
form
mani
region
also
result
appar
displac
exist
subtyp
subtyp
b
south
china
mani
subtyp
kinshasa
democrat
republ
congo
subtyp
b
southern
brazil
fig
displac
could
due
introduct
subtyp
c
popul
differ
transmiss
rout
heterosexu
transmiss
versu
intraven
drug
use
increas
sexual
activ
exampl
commerci
sex
worker
subtyp
might
initi
predomin
specif
transmiss
group
littl
support
evid
suggest
subtyp
b
c
also
refer
e
less
transmiss
specif
rout
specif
ethnic
group
specif
cell
type
addit
initi
predomin
gener
lost
epidem
exampl
thailand
subtyp
b
segreg
intraven
drug
user
heterosexu
respect
late
uniformli
mix
thai
popul
recent
studi
attempt
establish
ex
vivo
pathogen
transmiss
fit
differ
hiv
type
group
subtyp
ex
vivo
pathogen
fit
previous
describ
rel
replic
capac
primari
blood
cell
cell
pbmc
turn
might
relat
virul
contrast
ex
vivo
transmiss
fit
measur
compet
primari
isol
cell
dendrit
lineag
deriv
blood
monocyt
human
skin
futur
dual
competit
experi
use
vagin
cervic
biopsi
explant
might
best
model
transmiss
fit
first
establish
pathogen
fit
virul
hiv
pairwis
competit
done
eight
six
group
group
isol
subtyp
subtyp
b
subtyp
c
subtyp
subtyp
pbmc
fig
virus
classifi
use
either
coreceptor
entri
hiv
isol
phenotyp
compet
follow
fit
order
base
competit
observ
fig
group
subtyp
b
greater
fit
subtyp
c
turn
greater
group
show
lowest
fit
except
subtyp
c
order
reflect
preval
human
lentivirus
human
popul
propos
rate
transmiss
effici
subtyp
c
isol
least
less
fit
isol
group
subtyp
asid
subtyp
c
subtyp
shown
signific
fit
differ
group
subtyp
c
isol
preferenti
non
syncytiuminduc
nsi
throughout
diseas
wherea
infect
isol
subtyp
result
switch
viru
approxim
late
diseas
case
rare
subtyp
c
isol
obtain
infect
zimbabwean
late
diseas
even
switch
restor
fit
compar
group
isol
nankya
et
al
unpublish
data
caus
differenti
spread
differenti
spread
human
lentivirus
host
popul
control
transmiss
effici
opportun
collect
refer
r
ref
sever
model
microparasit
expans
human
propos
assum
earli
stage
epidem
rate
infect
dydt
simpli
increas
function
number
infect
individu
infecti
period
v
rate
move
noninfecti
state
probabl
infect
new
host
frequenc
sexual
contact
c
ref
opportun
transmiss
relat
number
sexual
contact
frequent
acut
infect
asymptomat
period
diseas
aid
infect
individu
without
period
highest
load
therefor
exponenti
growth
infect
earli
could
primarili
result
transmiss
acut
infect
men
sex
men
intraven
drug
user
howev
heterosexu
popul
reduc
frequenc
sexual
contact
donor
might
transmit
recipi
long
asymptomat
period
year
infect
moder
viral
load
acut
earli
infect
stage
month
high
viral
load
low
virul
could
lead
longer
asymptomat
period
could
also
increas
opportun
transmiss
box
similarli
poor
fit
group
compar
group
isol
found
competit
carri
pbmc
ex
vivo
pathogen
fit
dendritictcel
cultur
ex
vivo
transmiss
fit
relat
ex
vivo
model
poor
transmiss
effici
well
document
compar
human
popul
circul
contrast
subtyp
c
isol
similar
ex
vivo
transmiss
fit
compar
group
subtyp
b
isol
langerhan
cell
even
though
subtyp
c
isol
least
less
fit
pbmc
cultur
vivo
observ
indic
subtyp
c
transmit
effici
group
isol
human
cohort
rhesu
macaqu
use
sivhiv
env
chimer
viru
ex
vivo
vivo
observ
impli
subtyp
c
effici
transmit
less
virul
group
isol
group
n
might
limit
expans
human
popul
due
poor
host
adapt
transmiss
effici
contrast
group
seem
virul
well
transmiss
therefor
progenitor
group
lineag
might
fit
human
infect
promot
adapt
rapid
evolut
passag
human
popul
new
founder
event
segreg
human
popul
central
africa
might
led
subsequ
diverg
subtyp
subtyp
probabl
evolv
diverg
similar
select
pressur
unless
infect
human
popul
distinct
genet
polymorph
effect
virul
adapt
human
popul
follow
attenu
lethal
virul
might
howev
occur
differ
rate
diverg
clade
divers
hla
type
signific
role
evolut
subtyp
predomin
africa
subtyp
c
might
attenu
virul
faster
rate
subtyp
b
infect
caucasian
popul
lower
hla
divers
develop
world
contrast
subtyp
c
domin
south
africa
increas
proport
subtyp
recombin
form
kenya
number
case
increas
region
epidem
except
kinshasa
number
infect
specif
year
subdivid
subtyp
c
yellow
nonsubtypec
maroon
infect
b
schemat
represent
pathogen
fit
human
lentivirus
deriv
pairwis
dual
competit
experi
colour
oval
plot
fit
primari
isol
compet
isol
type
group
subtyp
axi
mean
fit
equal
fit
compar
fit
primari
isol
compet
isol
differ
type
group
subtyp
oval
encompass
fit
x
fit
valu
least
primari
isol
main
preval
reduc
virul
subtyp
c
might
advanc
stage
attenu
subtyp
less
virul
subtyp
subtyp
c
infect
might
result
slower
diseas
progress
longer
period
asymptomat
infect
opportun
transmiss
would
associ
increas
r
see
equat
box
support
model
disproportion
expans
subtyp
c
human
popul
fig
transmiss
effici
subtyp
c
must
greater
compar
group
strain
preliminari
data
suggest
subtyp
c
transmit
effici
group
subtyp
therefor
decreas
virul
could
key
role
spread
subtyp
c
increas
opportun
transmiss
far
comparison
cohort
infect
subtyp
c
subtyp
show
similar
higher
viral
load
subtyp
cinfect
individu
initi
observ
would
argu
possibl
subtyp
c
attenu
would
support
popular
assumpt
subtyp
c
virul
howev
studi
natur
histori
progress
patient
infect
subtyp
subtyp
b
two
studi
describ
faster
diseas
progress
individu
infect
subtyp
compar
subtyp
aor
subtyp
cinfect
individu
uganda
tanzania
possibl
greater
subtyp
virul
attribut
higher
propens
switch
phenotyp
aggress
syncytiuminduc
si
phenotyp
contrast
subtyp
c
rare
switch
phenotyp
recent
present
sixteenth
intern
aid
confer
toronto
canada
interim
analys
diseas
progress
describ
cohort
subtyp
cand
dinfect
women
recruit
acut
earli
infect
follow
mean
month
mean
slope
tcell
declin
subtyp
cinfect
women
zimbabw
slower
subtyp
aand
dinfect
women
uganda
p
howev
differ
mean
viral
load
month
countri
differ
subtyp
slower
diseas
progress
describ
slower
declin
tcell
count
attribut
factor
opportunist
infect
sexual
activ
diet
age
weight
apart
infect
subtyp
c
versu
subtyp
bantu
corridor
extend
zimbabw
uganda
frequenc
hlaa
b
c
allel
host
polymorph
exampl
delet
promot
polymorph
similar
could
rule
obviou
human
genet
differ
skew
evolut
attenu
infecti
pathogen
remain
contenti
mani
doubt
spread
human
popul
lead
decreas
virul
isol
actual
gain
replic
pathogen
fit
infect
human
host
howev
gain
might
suffici
revers
loss
pathogen
fit
occur
transmiss
earli
diseas
extrem
genet
bottleneck
follow
transmiss
reduc
popul
size
divers
least
vitro
studi
indic
genet
reduct
correl
signific
fit
loss
clone
establish
infect
must
evad
immun
system
result
yet
anoth
seri
genet
bottleneck
reduc
fit
therefor
attenu
virul
might
occur
net
fit
loss
transmiss
earli
diseas
greater
increas
pathogen
fit
diseas
progress
transmiss
event
greater
divers
hla
allel
african
popul
compar
caucasian
popul
might
result
stronger
immun
pressur
human
popul
possibl
faster
rate
attenu
global
domin
subtyp
c
relat
attenu
virul
subtyp
c
infect
lead
slower
diseas
progress
opportun
new
transmiss
event
question
might
hold
key
futur
epidem
could
provid
new
focu
arv
treatment
vaccin
design
